Inhibition of hepatic apolipoprotein A-I gene expression by histamine
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 823, 49-57
Abstract
No abstract availableKeywords
Funding Information
- University of Florida Jacksonville College of Medicine
This publication has 38 references indexed in Scilit:
- High-Throughput Analysis Identifying Drugs That Regulate Apolipoprotein A-I SynthesisASSAY and Drug Development Technologies, 2017
- Novel function of histamine signaling in hyperlipidemia‐induced atherosclerosis: Histamine H1 receptors protect and H2 receptors accelerate atherosclerosisPathology International, 2015
- High-Density Lipoprotein as a Therapeutic TargetJAMA, 2007
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by PioglitazoneBiochemical and Biophysical Research Communications, 2000
- The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by FibratesJournal of Biological Chemistry, 1998
- Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.Journal of Biological Chemistry, 1994
- A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemiaJournal of Immunological Methods, 1994
- The association of mast cells and atherosclerosis: A morphologic study of early atherosclerotic lesions in young peopleHuman Pathology, 1994
- Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell linesInflammation Research, 1991